European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomas. (28th November 2019)
- Record Type:
- Journal Article
- Title:
- European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomas. (28th November 2019)
- Main Title:
- European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications – actinic keratoses, Bowen's disease and basal cell carcinomas
- Authors:
- Morton, C.A.
Szeimies, R.‐M.
Basset‐Seguin, N.
Calzavara‐Pinton, P.
Gilaberte, Y.
Hædersdal, M.
Hofbauer, G.F.L.
Hunger, R.E.
Karrer, S.
Piaserico, S.
Ulrich, C.
Wennberg, A.‐M.
Braathen, L.R. - Abstract:
- Abstract: Topical photodynamic therapy (PDT) is a widely approved therapy for actinic keratoses, Bowen's disease (squamous cell carcinoma in situ ), superficial and certain thin basal cell carcinomas. Recurrence rates when standard treatment protocols are used are typically equivalent to existing therapies, although inferior to surgery for nodular basal cell carcinoma. PDT can be used both as lesional and field therapies and has the potential to delay/reduce the development of new lesions. A protocol using daylight to treat actinic keratoses is widely practised, with conventional PDT using a red light after typically a 3‐h period of occlusion employed for other superficial skin cancer indications as well as for actinic keratoses when daylight therapy is not feasible. PDT is a well‐tolerated therapy although discomfort associated with conventional protocol may require pain‐reduction measures. PDT using daylight is associated with no or minimal pain and preferred by patient. There is an emerging literature on enhancing conventional PDT protocols or combined PDT with another treatment to increase response rates. This guideline, published over two parts, considers all current approved and emerging indications for the use of topical PDT in dermatology, prepared by the PDT subgroup of the European Dermatology Forum guidelines committee. It presents consensual expert recommendations reflecting current published evidence.
- Is Part Of:
- Journal of the European Academy of Dermatology and Venereology. Volume 33:Number 12(2019)
- Journal:
- Journal of the European Academy of Dermatology and Venereology
- Issue:
- Volume 33:Number 12(2019)
- Issue Display:
- Volume 33, Issue 12 (2019)
- Year:
- 2019
- Volume:
- 33
- Issue:
- 12
- Issue Sort Value:
- 2019-0033-0012-0000
- Page Start:
- 2225
- Page End:
- 2238
- Publication Date:
- 2019-11-28
- Subjects:
- Dermatology -- Periodicals
Sexually transmitted diseases -- Periodicals
616.5 - Journal URLs:
- https://onlinelibrary.wiley.com/journal/14683083 ↗
http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=jdv ↗
http://www.sciencedirect.com/science/journal/09269959 ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0926-9959;screen=info;ECOIP ↗
http://www.blackwell-synergy.com/loi/jdv ↗ - DOI:
- 10.1111/jdv.16017 ↗
- Languages:
- English
- ISSNs:
- 0926-9959
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4741.624000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 17309.xml